LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline NRG Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher OSS Q1 2026 Earnings Surprise Profitability Despite Revenue Uncertainty CLDT Q1 2026 Earnings EPS Surpasses Expectations Narrowing Loss GABC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction HTBK Q4 2025 Earnings Slight EPS Miss Amid Stable Performance